hims, inc. manufactures men's wellness products. it offers products, including hair loss prevention medicines, sexual wellness products, skincare products, and oral care products. the company also provides sweaters, jackets, corduroy, sport coats, wool overcoat, leather boots, flannel, shirts, caps, and candles. it sells its products online. the company was incorporated in 2013 and is based in san francisco, california.
Company profile
Ticker
HIMS
Exchange
Website
CEO
Andrew Dudum
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Oaktree Acquisition Corp.
SEC CIK
Corporate docs
Subsidiaries
Hims, Inc. • H&H Derm, LLC • H&H Healthcare Management, Inc. • H&H Pharmacy Management, Inc. • Hims & Hers UK Limited ...
HIMS stock data
Latest filings (excl ownership)
10-Q
2024 Q1
Quarterly report
6 May 24
8-K
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
6 May 24
ARS
2023 FY
Annual report to shareholders
26 Apr 24
8-K
Departure of Directors or Certain Officers
26 Apr 24
8-K/A
Departure of Directors or Certain Officers
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
8-K
Departure of Directors or Certain Officers
3 Apr 24
S-8
Registration of securities for employees
26 Feb 24
10-K
2023 FY
Annual report
26 Feb 24
8-K
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
26 Feb 24
Transcripts
HIMS
Earnings call transcript
2024 Q1
6 May 24
HIMS
Earnings call transcript
2023 Q4
26 Feb 24
HIMS
Earnings call transcript
2023 Q3
6 Nov 23
HIMS
Earnings call transcript
2023 Q2
7 Aug 23
HIMS
Earnings call transcript
2023 Q2
7 Aug 23
HIMS
Earnings call transcript
2023 Q1
8 May 23
HIMS
Earnings call transcript
2022 Q4
27 Feb 23
HIMS
Earnings call transcript
2022 Q3
8 Nov 22
HIMS
Earnings call transcript
2022 Q2
9 Aug 22
HIMS
Earnings call transcript
2022 Q1
10 May 22
Latest ownership filings
4
Anja Manuel
9 May 24
4
Christopher D Payne
9 May 24
144
Notice of proposed sale of securities
9 May 24
4
Andrew Dudum
3 May 24
4
Melissa Baird
3 May 24
144
Notice of proposed sale of securities
3 May 24
144
Notice of proposed sale of securities
2 May 24
144
Notice of proposed sale of securities
1 May 24
4
Soleil Boughton
1 May 24
3
Anja Manuel
1 May 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 58.85 mm | 58.85 mm | 58.85 mm | 58.85 mm | 58.85 mm | 58.85 mm |
Cash burn (monthly) | 2.47 mm | (no burn) | 2.85 mm | 3.39 mm | (no burn) | (no burn) |
Cash used (since last report) | 18.23 mm | n/a | 21.01 mm | 24.97 mm | n/a | n/a |
Cash remaining | 40.63 mm | n/a | 37.84 mm | 33.89 mm | n/a | n/a |
Runway (months of cash) | 16.4 | n/a | 13.3 | 10.0 | n/a | n/a |
Institutional ownership, Q4 2023
50.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 139 |
Opened positions | 20 |
Closed positions | 77 |
Increased positions | 46 |
Reduced positions | 44 |
13F shares | Current |
---|---|
Total value | 548.23 bn |
Total shares | 104.21 mm |
Total puts | 305.30 k |
Total calls | 76.40 k |
Total put/call ratio | 4.0 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 14.17 mm | $126.14 bn |
Forerunner Partners III | 9.76 mm | $0.00 |
NewView HMS SPV | 9.70 mm | $0.00 |
Institutional Venture Management XV | 7.72 mm | $68.73 bn |
Redpoint Management | 7.58 mm | $67.44 bn |
Redpoint Ventures VI | 7.58 mm | $78.42 mm |
Oaktree Acquisition | 6.79 mm | $0.00 |
Marshall Wace | 5.27 mm | $46.90 bn |
NewView Capital Fund I | 3.94 mm | $0.00 |
Foresite Capital Management V | 3.83 mm | $34.12 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 May 24 | Manuel Anja | RSU Class A Common Stock | Grant | Acquire A | No | No | 0 | 30,120 | 0.00 | 30,120 |
8 May 24 | Payne Christopher D | RSU Class A Common Stock | Grant | Acquire A | No | No | 0 | 30,120 | 0.00 | 30,120 |
3 May 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 12.285 | 700 | 8.60 k | 538,932 |
3 May 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 11.5691 | 6,014 | 69.58 k | 539,632 |
3 May 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 12.27 | 500 | 6.14 k | 545,646 |
3 May 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 11.5774 | 4,536 | 52.52 k | 546,146 |
3 May 24 | Melissa Baird | Class A Common Stock | Option exercise | Acquire M | No | Yes | 0.4 | 11,750 | 4.70 k | 550,682 |
3 May 24 | Melissa Baird | Stock Option Class A Common Stock | Option exercise | Dispose M | No | Yes | 0.4 | 11,750 | 4.70 k | 704,908 |
2 May 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 12.079 | 6,714 | 81.10 k | 538,932 |
2 May 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 12.078 | 5,036 | 60.82 k | 545,646 |
News
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
7 May 24
Why Hims & Hers Health Stock Is Rising Today
7 May 24
Hims & Hers Health's Model 'Proving Effective': 2 Analysts Examine Q1 Earnings
7 May 24
Deutsche Bank Maintains Hold on Hims & Hers Health, Raises Price Target to $16
7 May 24
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
7 May 24
Press releases
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
6 May 24
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
15 Apr 24
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
3 Apr 24
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
11 Mar 24
Thinking about buying stock in Infobird, PubMatic, Hims & Hers Health, FibroGen, or Alpha Metallurgical Resources?
27 Feb 24